首頁 › 過重 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 過重 臨床試驗
14 項針對 過重 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Abington Medical Specialists, Horsham · 距離 16 英里
- Family Practice Associates, Wilmington · 距離 25 英里
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Clinical Renal Associates Ltd., Media · 距離 12 英里
- Suburban Research Associates, West Chester · 距離 24 英里
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Keystone Clinical Studies, Plymouth Meeting · 距離 12 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Philadelphia
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Suburban Research Associates - West Chester Office, West Chester · 距離 24 英里
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, Philadelphia
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
招募中3 期
- UPA Ctr Weight and Eating Dis, Philadelphia
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 距離 12 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Philadelphia
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Philadelphia
An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents
招募中歡迎健康志工
- Drexel University, Philadelphia
其他城市的 過重 試驗
- San Antonio, TX34 項研究
- Houston, TX33 項研究
- Chicago, IL29 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Dallas, TX20 項研究
- Atlanta, GA20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Austin, TX18 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。